Cargando…
Acute kidney injury defined by cystatin C may be superior for predicting the outcomes of liver cirrhosis with acute gastrointestinal bleeding
BACKGROUND & AIMS: Acute kidney injury (AKI) is conventionally evaluated by a dynamic change of serum creatinine (Scr). Cystatin C (CysC) seems to be a more accurate biomarker for assessing kidney function. This retrospective multicenter study aims to evaluate whether AKI re-defined by CysC can...
Autores principales: | Hong, Cen, Zhu, Qiang, Li, Yiling, Tang, Shanhong, Lin, Su, Yang, Yida, Yuan, Shanshan, Shao, Lichun, Wu, Yunhai, Liu, Bang, Li, Bimin, Meng, Fanping, Chen, Yu, Hong, Min, Qi, Xingshun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890530/ https://www.ncbi.nlm.nih.gov/pubmed/35225149 http://dx.doi.org/10.1080/0886022X.2022.2039193 |
Ejemplares similares
-
Development and Validation of CAGIB Score for Evaluating the Prognosis of Cirrhosis with Acute Gastrointestinal Bleeding: A Retrospective Multicenter Study
por: Bai, Zhaohui, et al.
Publicado: (2019) -
Effect of Body Mass Index on the Prognosis of Liver Cirrhosis
por: Yin, Yue, et al.
Publicado: (2021) -
Practice guidance for the use of terlipressin for liver
cirrhosis–related complications
por: Qi, Xingshun, et al.
Publicado: (2022) -
Association of conventional haemostasis and coagulation tests with the risk of acute upper gastrointestinal bleeding in liver cirrhosis: a retrospective study
por: Li, Jing, et al.
Publicado: (2016) -
No Benefit of Hemostatic Drugs on Acute Upper Gastrointestinal Bleeding in Cirrhosis
por: An, Yang, et al.
Publicado: (2020)